Linzagolix (KLH-2109; OBE-2109) 是一种有效的，非多肽，口服有效的 GnRH 拮抗剂。可用于子宫肌瘤、子宫内膜异位症、子宫腺肌症研究。
| Cas No. | 935283-04-8 |
| 别名 | 林扎戈利,KLH-2109; OBE-2109 |
| 分子式 | C22H15F3N2O7S |
| 分子量 | 508.42 |
| 溶解度 | DMSO : 125 mg/mL (245.86 mM; Need ultrasonic) |
| 储存条件 | Store at -20°C |
| General tips | For obtaining a higher solubility , please warm the tube at 37 ℃ and shake it in the ultrasonic bath for a while. |
| Shipping Condition | Evaluation sample solution : ship with blue ice
All other available size: ship with RT , or blue ice upon request |
| 产品描述 | Linzagolix (KLH-2109; OBE-2109) is a potent, non-peptide, and orally active GnRH antagonist. Linzagolix can be used for uterine fibroids, endometriosis, adenomyosis research[1]. [1]. Susan Dababou, et al. Linzagolix: a new GnRH-antagonist under investigation for the treatment of endometriosis and uterine myomas. Expert Opin Investig Drugs. 2021 Sep;30(9):903-911. |
